These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 4668366

  • 21. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract] [Full Text] [Related]

  • 22. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul 19; 16(15):61-2. PubMed ID: 4843632
    [No Abstract] [Full Text] [Related]

  • 23. The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics.
    Segatore M, Miller M.
    SCI Nurs; 1995 Mar 19; 12(1):2-7. PubMed ID: 7792578
    [Abstract] [Full Text] [Related]

  • 24. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L, Shellenberger MK, Davis CS.
    Adv Ther; 1998 Mar 19; 15(4):241-51. PubMed ID: 10186943
    [Abstract] [Full Text] [Related]

  • 25. Comparative profile of tizanidine in the management of spasticity.
    Lataste X, Emre M, Davis C, Groves L.
    Neurology; 1994 Nov 19; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [Abstract] [Full Text] [Related]

  • 26. [Myorelaxants].
    Taurand S.
    Soins; 1989 Mar 19; (522):I-II. PubMed ID: 2727727
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M, Kaul S, Lambie M.
    Dis Nerv Syst; 1974 Sep 19; 35(9):427-31. PubMed ID: 17894068
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Spasticity: a review.
    Young RR.
    Neurology; 1994 Nov 19; 44(11 Suppl 9):S12-20. PubMed ID: 7970006
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD.
    Neurology; 1994 Nov 19; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C, Muff S, Smolenski-Kautz S.
    Curr Med Res Opin; 1981 Nov 19; 7(6):374-83. PubMed ID: 7016449
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Spastic syndrome. More mobile again after stroke].
    MMW Fortschr Med; 2001 Mar 08; 143(10):46. PubMed ID: 11268740
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov 08; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.